smiles code,active ingredient,salt,relation,assay value,target disease,protein target,treatment concentration,treatment unit,exposure time (h),measurement,type,model type,description,dataset,REFERENCE_ID,ASSAY_TYPE,ASSAY_ORGANISM,ASSAY_STRAIN,TARGET_TYPE,SRC_ID,ASSAY_SOURCE,UPPER_VALUE,SD_MINUS,SD_PLUS,ACTIVITY_COMMENT
CC(C)(C)OC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CC(C)(C)OC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.003263,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)(C)OC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CC(C)(C)OC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,52.8,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(C)(C)OC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CC(C)(C)OC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.001029,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.73,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.67,Rat,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,3.1,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,12.5,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,1.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,35.5,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,48.8,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,62.6,Rat,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,27.7,Rat,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,2.6,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,F,CYP3A4,midazolam,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.094,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,62.5,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CS(=O)(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.2795,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.91,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.92,Rat,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,4.2,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,6.3,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,2.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,9.9,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,174.8,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,357.0,Rat,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,4.9,Rat,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.8,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,F,CYP3A4,midazolam,ORGANISM,14.0,HEOS,,,,
CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.000595,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,42.9,L. donovani,,,%,,% inhibition,In Vitro,,Leish macro in vitro at 10 uM,set10-1,1.0,F,L. donovani,MHOM/ET/67/L82,ORGANISM,14.0,HEOS,,,,
CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,50.61,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,CC(C)(C)CC(=O)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.001928,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.8,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.85,Rat,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,3.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,12.5,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,1.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,24.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,72.3,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,170.9,Rat,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,10.1,Rat,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,1.5,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,F,CYP3A4,midazolam,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.0058165,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,78.19,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(C1CC1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.01338225,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.89,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.88,Rat,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,3.8,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,6.3,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,2.1,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,12.5,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,138.6,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,230.9,Rat,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,7.5,Rat,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,1.9,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,F,CYP3A4,midazolam,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.01598,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,52.53,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,O=C(c1ccccc1)N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.06166,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)(C)OC(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(C)OC(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.005118,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)(C)OC(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(C)OC(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,22.25,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(C)(C)OC(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(C)OC(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.0099025,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.88,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.81,Rat,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,4.2,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,6.3,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,3.1,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,13.8,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,125.8,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,131.1,Rat,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,13.2,Rat,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,1.9,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,midazolam,ORGANISM,14.0,HEOS,,,,
CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.0026625,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,55.39,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(C)C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.007591,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.93,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.7,Rat,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,4.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,1.6,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,3.5,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,7.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,247.3,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,72.1,Rat,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,24.0,Rat,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,1.7,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,midazolam,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.000618,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,66.3,L. donovani,,,%,,% inhibition,In Vitro,,Leish macro in vitro at 10 uM,set10-1,1.0,F,L. donovani,MHOM/ET/67/L82,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,20.14,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.001465,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccccc1C(F)(F)F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 10 adm days",set10-1,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,12.5,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,3.5,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.72,Rat,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.89,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.008,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.047,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 10 adm days",set10-1,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,2.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,11.8,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,146.9,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,79.3,Rat,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,21.8,Rat,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,2.1,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,midazolam,ORGANISM,14.0,HEOS,,,,
Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.008383,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,78.48,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1noc(C)c1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.0030365,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.85,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.67,Rat,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,3.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,12.5,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,2.1,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,16.6,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,104.6,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,61.8,Rat,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,28.1,Rat,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,2.9,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,midazolam,ORGANISM,14.0,HEOS,,,,
Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.006931,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,67.36,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ncsc1C(=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.01102,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccccc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.016605,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccccc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,57.89,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=C(c1ccccc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccccc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.007457,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,3.1,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,4.1,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.77,Rat,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.88,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.015,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.028,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,54.32,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,16.6,Rat,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,4.4,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,midazolam,ORGANISM,14.0,HEOS,,,,
O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.00783,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,44.45,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.020723,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 10 adm days",set10-1,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,104.6,Rat,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,130.8,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,13.2,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1ccc(F)cc1)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,3.1,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,0.015,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,0.023,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,38.5,L. donovani,,,%,,% inhibition,In Vitro,,Leish macro in vitro at 10 uM,set10-1,1.0,F,L. donovani,MHOM/ET/67/L82,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,0.038,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 5 adm days",set10-1,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10-1,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,0.028,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,0.041,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,0.0165,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,30.2,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,midazolam,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,107.6,Mouse,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,0.41,Mouse,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,14.1,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,0.44,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,12.5,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,5.1,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,122.8,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,16.1,Mouse,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
O=C(c1c(F)cccc1F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1c(F)cccc1F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.009,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
O=C(c1c(F)cccc1F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1c(F)cccc1F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,48.87,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
O=C(c1c(F)cccc1F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,O=C(c1c(F)cccc1F)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.002,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cc3)CC2)cc1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 5 adm days",set10-1,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cc3)CC2)cc1,.,= ,0.015,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cc3)CC2)cc1,.,= ,70.97,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cc3)CC2)cc1,.,= ,0.027,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cc3)CC2)cc1,.,= ,0.022,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cc3)CC2)cc1,.,= ,0.025,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cc3)CC2)cc1,.,= ,,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,midazolam,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cc3)CC2)cc1,.,= ,34.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cc3)CC2)cc1,.,= ,51.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cc3)CC2)cc1,.,= ,0.65,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Fc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Fc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.04,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Fc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Fc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,32.49,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
Fc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Fc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.021,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3)CC2)cc1,.,= ,0.03,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3)CC2)cc1,.,= ,57.41,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3)CC2)cc1,.,= ,0.01399999999999999,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3)CC2)cc1,.,= ,11.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3)CC2)cc1,.,= ,58.4,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3)CC2)cc1,.,= ,29.7,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3)CC2)cc1,.,= ,4.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3)CC2)cc1,.,= ,0.77,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,.,= ,0.07200000000000001,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,.,= ,52.13,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,.,= ,0.038,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,.,= ,10.7,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,.,= ,18.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,.,= ,,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,midazolam,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,.,= ,66.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,.,= ,26.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,.,= ,2.5,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,.,= ,3.1,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3cccc(C(F)(F)F)c3)CC2)cc1,.,= ,0.79,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,Cc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,45.59,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
Cc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,Cc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,0.067,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,31.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,0.08,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,39.27,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,0.63,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,2.5,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,56.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,0.033,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,midazolam,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,FC(F)(F)c1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,10.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
COc1cccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,COc1cccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,0.09,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
COc1cccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,COc1cccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,36.76,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
COc1cccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,COc1cccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,0.056,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,0.092,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,16.34,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,0.76,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,4.9,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,0.057,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,8.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,15.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,midazolam,ORGANISM,14.0,HEOS,,,,
COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,56.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,31.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,2.0,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,COc1ccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,6.3,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3ccccc3C(F)(F)F)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3ccccc3C(F)(F)F)CC2)cc1,.,= ,0.009,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3ccccc3C(F)(F)F)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3ccccc3C(F)(F)F)CC2)cc1,.,= ,92.8,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3ccccc3C(F)(F)F)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3ccccc3C(F)(F)F)CC2)cc1,.,= ,18.7,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3ccccc3C(F)(F)F)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3ccccc3C(F)(F)F)CC2)cc1,.,= ,2.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3ccccc3C(F)(F)F)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3ccccc3C(F)(F)F)CC2)cc1,.,= ,1.6,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3ccccc3C(F)(F)F)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3ccccc3C(F)(F)F)CC2)cc1,.,= ,0.84,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3ccccc3C(F)(F)F)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3ccccc3C(F)(F)F)CC2)cc1,.,= ,63.82,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3ccccc3C(F)(F)F)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(Cc3ccccc3C(F)(F)F)CC2)cc1,.,= ,0.036,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cc1cccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,Cc1cccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,0.079,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cc1cccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,Cc1cccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,42.86,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
Cc1cccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,Cc1cccc(CN2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,0.044,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,.,= ,0.031,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,.,= ,41.46,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,.,= ,0.9,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,.,= ,4.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,.,= ,1.6,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,.,= ,3.1,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,.,= ,10.8,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,.,= ,160.6,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,.,= ,,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,midazolam,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,.,= ,1.7,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3nccs3)CC2)cc1,.,= ,0.017,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.87,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,3.1,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
Cc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.00699999999999999,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,54.07,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
Cc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.019,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,18.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
Cc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,2.0,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
Cc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,14.1,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cc1ccccc1CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,122.7,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cn3)CC2)cc1,.,= ,0.083,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cn3)CC2)cc1,.,= ,0.039,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(Cl)cn3)CC2)cc1,.,= ,50.69,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3cccc(C(F)(F)F)c3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3cccc(C(F)(F)F)c3)CC2)cc1,.,= ,0.21,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3cccc(C(F)(F)F)c3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3cccc(C(F)(F)F)c3)CC2)cc1,.,= ,0.312,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccn3)CC2)cc1,.,= ,0.051,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccn3)CC2)cc1,.,= ,54.98,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccn3)CC2)cc1,.,= ,0.024,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,5.0,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,0.68,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,115.0,Rat,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,39.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10-1,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,0.031,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,60.07,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,37.9,L. donovani,,,%,,% inhibition,In Vitro,,Leish macro in vitro at 10 uM,set10-1,1.0,F,L. donovani,MHOM/ET/67/L82,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,0.014,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 5 adm days",set10-1,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,0.025,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,59.52,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,102.0,Plasma,,,%,,% remaining,In Vitro,,"Stability, 4 hour",set10-1,1.0,A,Plasma,Dog,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,108.0,Blood,,,%,,% remaining,In Vitro,,"Stability, 4 hour",set10-1,1.0,A,Blood,Dog,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,96.0,Plasma,,,%,,% remaining,In Vitro,,"Stability, 4 hour",set10-1,1.0,A,Plasma,rat,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,115.0,Blood,,,%,,% remaining,In Vitro,,"Stability, 4 hour",set10-1,1.0,A,Blood,rat,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,97.0,Plasma,,,%,,% remaining,In Vitro,,"Stability, 4 hour",set10-1,1.0,A,Plasma,human,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,101.0,Blood,,,%,,% remaining,In Vitro,,"Stability, 4 hour",set10-1,1.0,A,Blood,human,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,0.017,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,6.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,midazolam,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,midazolam,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,9.8,CYP2C19,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP2C19,unknown,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,8.1,CYP2C9,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP2C9,unknown,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,45.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,0.52,Mouse,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,70.0,Mouse,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,2.41,PKA,,,none,,pKa(1),In Vitro,,pKa measurement,set10-1,1.0,A,PKA,unknown,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,15.0,Rat,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,0.53,Dog,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Dog,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,12.1,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,24.0,Dog,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Dog,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,73.0,Dog,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Dog,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,9682.0,SGF,,,ug/ml,,Equilibrium,In Vitro,,"Solubility, 24 hour",set10-1,1.0,A,SGF,37oC,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,12.7,FeSSIF,,,ug/ml,,Equilibrium,In Vitro,,"Solubility, 24 hour",set10-1,1.0,A,FeSSIF,37oC,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,53.1,20 mM Citrate - pH 3,,,ug/ml,,Equilibrium,In Vitro,,"Solubility, 24 hour",set10-1,1.0,A,20 mM Citrate - pH 3,37oC,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,1430.0,50 mM Phosphate - pH 2,,,ug/ml,,Equilibrium,In Vitro,,"Solubility, 24 hour",set10-1,1.0,A,50 mM Phosphate - pH 2,37oC,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,99.0,dog,,,%,,% bound,In Vitro,,protein binding,set10-1,1.0,A,dog,plasma,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,99.8,Human,,,%,,% bound,In Vitro,,protein binding,set10-1,1.0,A,Human,Liver Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,,Met ID,,,none,,Report,In Vitro,,Metabolism,set10-1,1.0,A,Met ID,unknown,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,Nifedipine,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,99.6,10% serum RPMI,,,%,,% bound,In Vitro,,protein binding,set10-1,1.0,A,10% serum RPMI,media,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10-1,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10-1,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 5 mg/kg, 20 adm days",set10-1,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 10 mg/kg, 20 adm days",set10-1,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 50 mg/kg, 20 adm days",set10-1,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 100 mg/kg, 20 adm days",set10-1,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,25.0,Mouse,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Mouse,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,0.33,Rat,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Rat,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,0.031,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,0.017,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cl.FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,Cl,= ,0.01966666666666666,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,.,= ,0.67,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,.,= ,4.9,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,.,= ,4.2,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,.,= ,49.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,.,= ,36.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,.,= ,,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,midazolam,ORGANISM,14.0,HEOS,,,,
Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,.,= ,0.7,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,.,= ,0.022,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,.,= ,53.1,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,.,= ,0.028,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,Fc1cnc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)nc1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 5 adm days",set10-1,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,.,= ,,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,midazolam,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,.,= ,196.5,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,.,= ,1.8,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,.,= ,3.5,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,.,= ,1.6,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,.,= ,4.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,.,= ,0.92,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,.,= ,0.017,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,.,= ,53.88,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,.,= ,8.8,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ncccn3)CC2)cc1,.,= ,0.023,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,15.5,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,4.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,50.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,4.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,0.86,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,0.013,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,51.5,L. donovani,,,%,,% inhibition,In Vitro,,Leish macro in vitro at 10 uM,set10-1,1.0,F,L. donovani,MHOM/ET/67/L82,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,0.007,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,4.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,midazolam,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,N#Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cc1,.,= ,112.1,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,N#Cc1ccccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,4.9,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
N#Cc1ccccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,N#Cc1ccccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.88,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,N#Cc1ccccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,4.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
N#Cc1ccccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,N#Cc1ccccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,12.8,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,N#Cc1ccccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,135.5,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,N#Cc1ccccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,5.2,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
N#Cc1ccccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,N#Cc1ccccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.003,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,N#Cc1ccccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,60.9,L. donovani,,,%,,% inhibition,In Vitro,,Leish macro in vitro at 10 uM,set10-1,1.0,F,L. donovani,MHOM/ET/67/L82,ORGANISM,14.0,HEOS,,,,
N#Cc1ccccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,N#Cc1ccccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,39.69,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
N#Cc1ccccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,N#Cc1ccccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.008,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,4.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,25.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,33.4,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,51.8,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,16.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,0.015,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,56.87,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,0.032,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,4.8,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,0.74,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cn1,Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cn1,.,= ,0.34,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cn1,Cc1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)cn1,.,= ,0.151,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cc1cncc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,Cc1cncc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,0.027,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cc1cncc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,Cc1cncc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,55.56,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
Cc1cncc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,Cc1cncc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,0.009,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cc1cncc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,Cc1cncc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,0.6,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
Cc1cncc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,Cc1cncc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,168.6,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1cncc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,Cc1cncc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,10.3,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1cncc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,Cc1cncc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,1.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
Cc1cncc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,Cc1cncc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,1.6,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
Cc1cncc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,Cc1cncc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,0.9,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cc1cncc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,Cc1cncc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,4.8,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3C(F)(F)F)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3C(F)(F)F)CC2)cc1,.,= ,0.015,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3C(F)(F)F)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3C(F)(F)F)CC2)cc1,.,= ,60.83,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3C(F)(F)F)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(c3ccccc3C(F)(F)F)CC2)cc1,.,= ,0.036,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,.,= ,0.003,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,.,= ,0.009,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10-1,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,.,= ,0.69,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,.,= ,4.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,.,= ,25.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,.,= ,4.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,.,= ,43.9,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,.,= ,0.01,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,.,= ,28.1,L. donovani,,,%,,% inhibition,In Vitro,,Leish macro in vitro at 10 uM,set10-1,1.0,F,L. donovani,MHOM/ET/67/L82,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,.,= ,0.003,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,.,= ,39.5,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,0.47,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,3.0,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,1.6,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,25.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,2.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,111.2,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,15.6,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,12.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,0.00235,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,0.0066,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)cc1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 5 adm days",set10-1,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,0.88,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,3.9,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,2.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,13.1,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,132.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,2.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,0.00218,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,28.0,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,CS(=O)(=O)c1ccc(N2CCC(N(c3ccc(Cl)cc3)c3cccnc3)CC2)cc1,.,= ,0.0057,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(F)c(F)c3)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(F)c(F)c3)CC2)cc1,.,= ,0.8,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(F)c(F)c3)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(F)c(F)c3)CC2)cc1,.,= ,4.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(F)c(F)c3)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(F)c(F)c3)CC2)cc1,.,= ,6.3,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(F)c(F)c3)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(F)c(F)c3)CC2)cc1,.,= ,4.2,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(F)c(F)c3)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(F)c(F)c3)CC2)cc1,.,= ,23.5,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(F)c(F)c3)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(F)c(F)c3)CC2)cc1,.,= ,73.7,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(F)c(F)c3)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(F)c(F)c3)CC2)cc1,.,= ,4.3,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(F)c(F)c3)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(F)c(F)c3)CC2)cc1,.,= ,0.0018,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(F)c(F)c3)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(F)c(F)c3)CC2)cc1,.,= ,0.003,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,49.1,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(C)(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.03,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.011,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,5.3,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CC(C)(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,50.0,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,34.6,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,1.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
CC(C)(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,25.0,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CC(C)(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,3.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CC(C)(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.74,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1ccccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,CN(C)S(=O)(=O)c1ccccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,.,= ,0.95,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1ccccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,CN(C)S(=O)(=O)c1ccccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,.,= ,3.9,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1ccccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,CN(C)S(=O)(=O)c1ccccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,.,= ,25.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1ccccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,CN(C)S(=O)(=O)c1ccccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,.,= ,3.8,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1ccccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,CN(C)S(=O)(=O)c1ccccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,.,= ,5.1,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1ccccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,CN(C)S(=O)(=O)c1ccccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,.,= ,2.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1ccccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,CN(C)S(=O)(=O)c1ccccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,.,= ,0.01,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1ccccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,CN(C)S(=O)(=O)c1ccccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,.,= ,9.28,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1ccccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,CN(C)S(=O)(=O)c1ccccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,.,= ,0.028,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1ccccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,CN(C)S(=O)(=O)c1ccccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,.,= ,340.5,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,0.94,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,4.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,25.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,4.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,6.7,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,257.9,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,7.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,0.015,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,10.37,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cccnc3)CC2)c1,.,= ,0.031,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)c1,CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)c1,.,= ,0.97,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)c1,CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)c1,.,= ,3.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)c1,CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)c1,.,= ,50.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)c1,CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)c1,.,= ,3.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)c1,CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)c1,.,= ,3.4,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)c1,CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)c1,.,= ,504.2,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)c1,CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)c1,.,= ,6.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)c1,CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)c1,.,= ,0.006,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)c1,CN(C)S(=O)(=O)c1cccc(N2CCC(N(c3ccc(C#N)cc3)c3cccnc3)CC2)c1,.,= ,0.011,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCC(C(C)=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CCC(C(C)=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,11.1,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCC(C(C)=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CCC(C(C)=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.02,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCC(C(C)=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CCC(C(C)=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,25.01,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CCC(C(C)=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CCC(C(C)=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.008,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCC(C(C)=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CCC(C(C)=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,10.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CCC(C(C)=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CCC(C(C)=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,156.1,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCC(C(C)=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CCC(C(C)=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,1.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
CCC(C(C)=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CCC(C(C)=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,12.5,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CCC(C(C)=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CCC(C(C)=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,4.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CCC(C(C)=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CCC(C(C)=O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.9,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,CN(C)S(=O)(=O)c1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,.,= ,0.011,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CN(C)S(=O)(=O)c1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,CN(C)S(=O)(=O)c1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,.,= ,0.006,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(=O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.82,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(=O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(=O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,4.2,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CC(=O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(=O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,6.3,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CC(=O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(=O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,1.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
CC(=O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(=O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,21.5,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(=O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(=O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,80.7,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(=O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(=O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,5.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CC(=O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(=O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.015,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(=O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(=O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,68.98,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(=O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(=O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.031,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.64,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.96,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,64.83,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.424,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,23.8,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,72.9,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,1.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,25.0,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,2.9,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,3.5,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,25.0,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,1.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,55.4,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,31.3,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.075,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.57,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(O)C(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,59.57,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(C)(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,1.072,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,64.25,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(C)(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(C)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.603,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.011,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,24.34,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.75,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,12.5,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,5.2,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,32.8,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,52.9,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.007,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.85,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,25.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,4.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,16.8,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,103.2,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.005,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,17.68,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,N#Cc1cc(C(F)(F)F)ccc1N1CCC(N(c2ccc(Cl)cc2)c2cccnc2)CC1,.,= ,0.01049999999999999,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cn1nc(C2CC2)cc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cn1nc(C2CC2)cc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.87,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cn1nc(C2CC2)cc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cn1nc(C2CC2)cc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,30.02,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
Cn1nc(C2CC2)cc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cn1nc(C2CC2)cc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,50.0,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
Cn1nc(C2CC2)cc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cn1nc(C2CC2)cc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,4.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
Cn1nc(C2CC2)cc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cn1nc(C2CC2)cc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,14.6,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cn1nc(C2CC2)cc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cn1nc(C2CC2)cc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,118.4,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
Cn1nc(C2CC2)cc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cn1nc(C2CC2)cc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.007,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
Cn1nc(C2CC2)cc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cn1nc(C2CC2)cc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,4.8,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
Cn1nc(C2CC2)cc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,Cn1nc(C2CC2)cc1N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.0135,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)(O)CN1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,CC(C)(O)CN1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,.,= ,0.07100000000000001,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)(O)CN1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,CC(C)(O)CN1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,.,= ,0.027,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)(O)CN1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,CC(C)(O)CN1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,.,= ,12.2,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)(O)CN1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,CC(C)(O)CN1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,.,= ,141.5,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)(O)CN1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,CC(C)(O)CN1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,.,= ,0.7,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
CC(C)(O)CN1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,CC(C)(O)CN1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,.,= ,2.2,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CC(C)(O)CN1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,CC(C)(O)CN1CCC(N(c2ccc(C#N)cc2)c2cccnc2)CC1,.,= ,0.41,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCC(C(C)O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CCC(C(C)O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,49.63,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CCC(C(C)O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CCC(C(C)O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.061,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CCC(C(C)O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CCC(C(C)O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,17.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CCC(C(C)O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CCC(C(C)O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,48.4,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCC(C(C)O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CCC(C(C)O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,35.8,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCC(C(C)O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CCC(C(C)O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,1.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
CCC(C(C)O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CCC(C(C)O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.73,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CCC(C(C)O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CCC(C(C)O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,4.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CCC(C(C)O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CCC(C(C)O)N1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,25.0,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3C#N)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3C#N)CC2)cc1,.,= ,0.004,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3C#N)CC2)cc1,N#Cc1ccc(N(c2cccnc2)C2CCN(c3ccc(C(F)(F)F)cc3C#N)CC2)cc1,.,= ,0.002,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cncnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cncnc3)CC2)cc1,.,= ,25.7,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cncnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cncnc3)CC2)cc1,.,= ,67.5,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cncnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cncnc3)CC2)cc1,.,= ,16.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cncnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cncnc3)CC2)cc1,.,= ,3.1,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cncnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cncnc3)CC2)cc1,.,= ,5.2,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cncnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cncnc3)CC2)cc1,.,= ,0.79,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cncnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cncnc3)CC2)cc1,.,= ,0.007,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cncnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cncnc3)CC2)cc1,.,= ,76.54,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cncnc3)CC2)cc1,FC(F)(F)c1ccc(N2CCC(N(c3ccc(C(F)(F)F)cc3)c3cncnc3)CC2)cc1,.,= ,0.011,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,0.64,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,4.3,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,1.6,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,1.6,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,4.4,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,53.7,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,32.3,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,9.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,0.01,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,48.07,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,0.02099999999999999,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,0.01595,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)nc3)CC2)cc1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10-1,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
CC(C)C(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)C(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,51.5,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(C)C(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)C(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.036,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)C(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)C(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,1.6,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
CC(C)C(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)C(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,25.0,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CC(C)C(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)C(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,3.9,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CC(C)C(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)C(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.76,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)C(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)C(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,29.8,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)C(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)C(O)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,58.2,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)(F)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(F)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.89,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)(F)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(F)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,5.1,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
CC(C)(F)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(F)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,3.1,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
CC(C)(F)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(F)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,1.8,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3.0,ORGANISM,14.0,HEOS,,,,
CC(C)(F)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(F)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,12.6,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)(F)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(F)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,138.1,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
CC(C)(F)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(F)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,16.0,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,testosterone,ORGANISM,14.0,HEOS,,,,
CC(C)(F)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(F)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.015,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
CC(C)(F)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(F)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,64.87,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
CC(C)(F)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,CC(C)(F)CN1CCC(N(c2ccc(C(F)(F)F)cc2)c2cccnc2)CC1,.,= ,0.025,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(C(c3ccccc3)C(F)(F)F)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(C(c3ccccc3)C(F)(F)F)CC2)cc1,.,= ,8.14,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(C(c3ccccc3)C(F)(F)F)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(C(c3ccccc3)C(F)(F)F)CC2)cc1,.,= ,8.139,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(C(c3ccccc3)C(F)(F)F)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(C(c3ccccc3)C(F)(F)F)CC2)cc1,.,= ,5.13,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(C(c3ccccc3)C(F)(F)F)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(C(c3ccccc3)C(F)(F)F)CC2)cc1,.,= ,5.131,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(C(c3ccccc3)C(F)(F)F)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(C(c3ccccc3)C(F)(F)F)CC2)cc1,.,= ,27.7,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(C(c3ccccc3)C(F)(F)F)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(C(c3ccccc3)C(F)(F)F)CC2)cc1,.,= ,62.6,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(C(c3ccccc3)C(F)(F)F)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(C(c3ccccc3)C(F)(F)F)CC2)cc1,.,= ,1.6,Phosphate Buffer - pH 6.5,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,Phosphate Buffer - pH 6.5,NEPH_RT,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(C(c3ccccc3)C(F)(F)F)CC2)cc1,FC(F)(F)c1ccc(N(c2cccnc2)C2CCN(C(c3ccccc3)C(F)(F)F)CC2)cc1,.,= ,0.61,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,93.18,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,0.00364999999999999,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,0.0054,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,0.005,T. cruzi,,,uM,,IC50,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,6.3,CYP3A4,,,uM,,IC50,In Vitro,,CYP Inhibition,set10-1,1.0,A,CYP3A4,unknown,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,56.0,Human,,,Min,,t (1 / 2),In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,12.5,0.01M HCl - pH 2,,,ug/ml,,Kinetic,In Vitro,,Solubility,set10-1,1.0,A,0.01M HCl - pH 2,NEPH_RT,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,4.9,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 7.4,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,5.0,gLogD,,,none,,logD,In Vitro,,Lipophilicity,set10-1,1.0,A,gLogD,pH 3,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,0.00915,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,,T. cruzi,,,%,,% inhibition,In Vivo,,"Chagas in vivo at 20 mg/kg, 20 adm days",set10-1,1.0,F,T. cruzi,Tulahuen Swiss po,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,56.9,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,56.9,L-6 cells,,,uM,,IC50,In Vitro,,Cytotoxicity in Vitro,set10-1,1.0,F,L-6 cells,Rat Skeletal Myoblast Cells,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,0.01,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,0.01,T. cruzi,,,uM,,IC90,In Vitro,,Chagas in Vitro,set10-1,1.0,F,T. cruzi,Tulahuen C4 (LacZ),ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,30.9,Human,,,uL/min/mg,,CLint in vitro,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,FC(F)(F)c1ccc(N(c2cncnc2)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1,.,= ,0.63,Human,,,none,,EH,In Vitro,,Metabolism,set10-1,1.0,A,Human,Microsomes,ORGANISM,14.0,HEOS,,,,
